Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This is an open-label, extension, Phase III study to evaluate the long-term safety and
efficacy of MRA in patients with RA who participated in Study MRA012JP.